RalA and RalB: antagonistic relatives in cancer cell migration
- PMID: 16103060
- DOI: 10.1158/0008-5472.CAN-04-1957
RalA and RalB: antagonistic relatives in cancer cell migration
Abstract
The Ral family of small G proteins has been implicated in tumorigenesis, invasion, and metastasis. However, little emphasis has been placed on clarifying the individual roles of the two Ral proteins, RalA and RalB, in these processes in view of their high sequence homology. Here we analyze the separate contributions of RalA and RalB in regulating cell migration, a necessary component of the invasive phenotype, in two human cancer cell lines; UMUC-3, a bladder carcinoma line, and the prostate carcinoma line, DU145. Although inhibiting RalA protein expression by approximately 80% with two different small interfering RNA duplexes had no effect on migration, inhibiting RalB expression to the same extent with two different duplexes resulted in a marked reduction in migration. Inhibiting RalB expression did trigger a significant loss of actin cytoskeleton fibers in UMUC-3 that was not seen with inhibition of RalA expression. Interestingly, simultaneous inhibition of RalA and RalB expression had no effect on migration. However, dual inhibition of RalA and RalB expression in UMUC-3 did result in an almost total loss of actin fibers as well as a reduction in proliferation, particularly in reduced serum conditions. These results suggest that RalA and RalB have different roles in cell migration and that they may in fact act as antagonists with regard to this phenotype. As further verification of this hypothesis, we found that expression of constitutively active RalA inhibited migration, whereas expression of constitutively active RalB stimulated migration, consistent with this model. In summary, we present the first demonstration that despite their significant sequence homology, RalA and RalB have nonoverlapping and opposing functions in cancer cell migration but overlapping functions in cell growth.
Similar articles
-
The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.Breast Cancer Res. 2021 Jun 12;23(1):65. doi: 10.1186/s13058-021-01438-3. Breast Cancer Res. 2021. PMID: 34118960 Free PMC article.
-
Phosphorylation of RalB is important for bladder cancer cell growth and metastasis.Cancer Res. 2010 Nov 1;70(21):8760-9. doi: 10.1158/0008-5472.CAN-10-0952. Epub 2010 Oct 12. Cancer Res. 2010. PMID: 20940393 Free PMC article.
-
Expression of ral GTPases, their effectors, and activators in human bladder cancer.Clin Cancer Res. 2007 Jul 1;13(13):3803-13. doi: 10.1158/1078-0432.CCR-06-2419. Clin Cancer Res. 2007. PMID: 17606711
-
The RAL Enigma: Distinct Roles of RALA and RALB in Cancer.Cells. 2022 May 14;11(10):1645. doi: 10.3390/cells11101645. Cells. 2022. PMID: 35626682 Free PMC article. Review.
-
A family affair: A Ral-exocyst-centered network links Ras, Rac, Rho signaling to control cell migration.Small GTPases. 2019 Sep;10(5):323-330. doi: 10.1080/21541248.2017.1310649. Epub 2017 May 12. Small GTPases. 2019. PMID: 28498728 Free PMC article. Review.
Cited by
-
Dual effects of Ral-activated pathways on p27 localization and TGF-β signaling.Mol Biol Cell. 2013 Jun;24(11):1812-24. doi: 10.1091/mbc.E13-01-0007. Epub 2013 Apr 10. Mol Biol Cell. 2013. PMID: 23576547 Free PMC article.
-
SH3BP1, an exocyst-associated RhoGAP, inactivates Rac1 at the front to drive cell motility.Mol Cell. 2011 Jun 10;42(5):650-61. doi: 10.1016/j.molcel.2011.03.032. Mol Cell. 2011. PMID: 21658605 Free PMC article.
-
Involvement of members of the Rab family and related small GTPases in autophagosome formation and maturation.Cell Mol Life Sci. 2011 Oct;68(20):3349-58. doi: 10.1007/s00018-011-0748-9. Epub 2011 Jun 18. Cell Mol Life Sci. 2011. PMID: 21687989 Free PMC article. Review.
-
Haploinsufficiency Interactions of RALBP1 and TP53 in Carcinogenesis.Cancers (Basel). 2021 Jan 12;13(2):255. doi: 10.3390/cancers13020255. Cancers (Basel). 2021. PMID: 33445456 Free PMC article.
-
The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral.Oncogene. 2011 Aug 25;30(34):3661-71. doi: 10.1038/onc.2011.93. Epub 2011 Mar 28. Oncogene. 2011. PMID: 21441953 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials